Skip to main content

Advertisement

Table 1 Clinical characteristics and outcome of 18 patients with idiopathic VF

From: Recurrent cardiac events in patients with idiopathic ventricular fibrillation, excluding patients with the Brugada syndrome

Baseline Characteristics ICD Therapy
Patient Age (years) sex CE Drug test to exclude Brugada PES AS NSVT IS Ind S Time to 1st AS (months) Follow-up (months) AAD during follow-up
1 47,M Sy-VF F SMVT 6 7 - - 4 17 sotalol
2 51,F CA F NI 7 21 - - 1 19 sotalol
3 66,M CA AJ VF - - - - - 5 -
4 70,F CA P NI - - 6(af) - - 19 amiodarone
5 46,M CA F NI - 1 1(af) - - 23 sotalol
6 20,M Sy-VF A VF - - 3(st-lp) - - 92 b-blocker
7 46,F CA P VF - 120 - - - 27 sotalol
8 40,M CA A NSVT 1 - - - 13 75 -
9 33,M Sy-VF F NSVT - 1 - - - 19 -
10 26,M CA F NI 1 - 3(st-lp) - 7 9 sotalol
11 33,F CA F NI - - - - - 18 -
12 50,F CA F SMVT 6 - 1(st) - 13 86 flecainide
13 25,M CA AJ + P NSVT - 1 - - - 62 -
14 36,M CA AJ NI 2 - 2(af) 4 27 55 sotalol
15 58,M Sy-VF AJ NI - - 3(af) 2 - 57 sotalol
16 44,M CA F + P NI - - - - - 48 -
17 28,M Sy-VF F VF 4 - 2(st) - 18 55 sotalol
18 35,M Sy-VF A SMVT - - - - - 59 -
  1. CE: clinical events; CA: cardiac arrest; Sy-VF: syncope with documented self-terminating polymorphic VT or VF
  2. PES: programmed electrical stimulation; M: male; F: female
  3. SM: sustained monomorphic; VT: ventricular tachycardia; VF: ventricular fibrillation
  4. NS: non sustained; NI: non inducibility; af: atrial fibrillation; st: sinus tachycardia; lp: lead problem
  5. AS: appropriate shock; IS: inappropriate shock; Ind S: indeterminate cause for shocks;
  6. AAD: antiarrhythmic drug; F: flécaïnide; AJ: ajmaline; P: procainamide